Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Tricase
Clinical trial register · Italy

Clinical Trials in Tricase, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca5 Gruppo Oncologico del Nord-Ovest4 Seagen, a wholly owned subsidiary of Pfizer3 ACADIA Pharmaceuticals Inc.2 Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Tricase

35 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Gruppo Oncologico del Nord-Ovest
Phase 3
244
San Giovanni Rotondo, Tricase, Rozzano, Orbassano, Aviano, Bari, Bologna, Crema
2026-09-01
Recruiting
AstraZeneca
Phase 3
915
Bari, Florence, Padova, Roma, Rozzano, Tricase
2026-07-16
Not yet open
University Medical Center Groningen
Not applicable
292
Florence, Lavagna, Milan, Nola, Reggio Emilia, Roma, Tricase
2026-07
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
DrugsCetuximab·Nab-paclitaxel·Gemcitabine
Revolution Medicines, Inc.
Phase 3
900
Milan, Padova, Roma, Tricase, Verona
2026-03-09
Recruiting
AstraZeneca
Phase 3
2,130
Meldola, Milan, Padova, Rozzano, Tricase
2026-02-03
Recruiting
Exciva GmbH
Phase 2/3
300
Rome, Tricase, Brescia, Milan, Palermo
2026-02-02
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Castellana Grotte, San Giovanni Rotondo, Tricase, Milan, Aviano, Pisa, Padova, Avellino
2025-12-31
Recruiting
Pfizer
Phase 3
800
Tricase, Roma, Padova, Florence, Milan
2025-12-11
Recruiting
Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
NCT07407465Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma
DrugsTrastuzumab deruxtecan·Capecitabine·Bevacizumab
Gruppo Oncologico del Nord-Ovest
Phase 2
42
Bari, Florence, Milan, Ravenna, Rozzano, Tricase, Modena, Roma
2025-10-20
Recruiting
Italian Translation and Validation of the GIDS-PD Scale for Parkinson's Disease
NCT07316751PARKINSON DISEASE (Disorder), Parkinson Disease
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
190
Milan, Padova, Tricase, Verona
2025-10-08
Recruiting
National Cancer Institute, Naples
Phase 2
130
Caserta, Naples, Avellino, Udine, Tricase, Frattamaggiore, Pozzuoli
2025-03-12
Recruiting
AstraZeneca
Phase 3
840
Cagliari, Florence, Milan, Naples, Padova, Rozzano, Torino, Tricase
2025-03-01
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2
36
Meldola, Tricase
2025-01-07
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 3
238
Brescia, Catania, Meldola, San Giovanni Rotondo, Florence, Tricase, Livorno, Lucca
2024-11-15
Recruiting
AstraZeneca
Phase 3
620
Florence, Milan, Naples, Padova, Roma, Rozzano, Tricase
2024-08-12
Active, closed
Gruppo Oncologico del Nord-Ovest
Phase 2
16
Monserrato, Meldola, San Giovanni Rotondo, Tricase, Milan, Padova, Pisa, Prato
2024-07-23
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2
25
Milan, Roma, Tricase
2024-06-03
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
380
Cefalù, Genova, Palermo, Roma, Tricase
2024-05-24
By invitation
ACADIA Pharmaceuticals Inc.
Phase 3
752
Brescia, Salerno, Tricase
2024-04-23
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Meldola, Tricase, Genoa, Candiolo, Ascoli Piceno, Bologna, Brescia, Milan
2023-12-12
Recruiting
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673Alzheimer's Disease Psychosis
DrugACP-204
ACADIA Pharmaceuticals Inc.
Phase 2/3
1,074
Brescia, Cefalù, Isernia, Milan, Roma, Salerno, Torino, Tricase
2023-11-14
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Tricase, Milan, Meldola, Borgo Roma, Alessandria, Genova, Parma, Pavia
2023-10-04
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Tricase, Genoa, Rozzano, Lombardy, Giugliano in Campania, Bari, Pozzuoli (NA), Lugo
2023-09-22
Active, closed
Hoffmann-La Roche
Phase 3
687
Tricase, Bologna, Rome, Genoa, Rozzano, Palermo, Verona
2023-09-14
Active, closed
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy
Theravance Biopharma
Phase 3
102
Bologna, Milan, Rome, Salerno, Terni, Trento, Tricase
2023-06-27
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Ancona, Brescia, Milan, Monza, Pisa, Roma, Torino, Tricase
2022-12-23
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Monserrato, Avellino, Rome, Tricase, Brescia, Milan, Naples, Verona
2022-10-24
Active, closed
Biogen
Phase 2
416
Tricase, Cefalù, Arzignano VI, Brescia, Milan, Perugia, Roma
2022-08-24
Active, closed
AstraZeneca
Phase 3
760
Arezzo, Florence, Milan, Roma, Rozzano, Tricase
2022-03-28
Active, closed
Denali Therapeutics Inc.
Phase 1/2
85
Brescia, Florence, Milan, Tricase
2022-02-01
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
Bari, Tricase, Milan, Bologna, Trieste
2020-08-20
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
100
Brescia, San Giovanni Rotondo, Tricase, Monza, Ancona, Ascoli Piceno, Bari, Bologna
2019-12-09
By invitation
Azienda Ospedaliera Cardinale G. Panico
Observational
900
Tricase
2019-09-01
Active, closed
Eisai Inc.
Phase 3
1,906
Tricase, Cefalù, Genova, Milan, Monza, Naples, Perugia, Pisa
2019-03-27
Active, closed
Exelixis
Phase 3
837
Tricase, Rozzano, Bologna, Brescia, Milan, Naples, Novara, Roma
2018-06-10
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/tricase

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Tricase.

How many clinical trials are recruiting in Tricase?

19 of the 35 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 12 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Tricase), 35 studies
PhaseStudiesRecruitingShare
Phase 3201057.1%
Phase 27420%
Phase 2/3338.6%
Not applicable215.7%
Observational215.7%
Phase 1/2102.9%

Most active sponsors

Lead sponsors with the most studies (Tricase)
Lead sponsorStudiesRecruiting
AstraZeneca54
Gruppo Oncologico del Nord-Ovest42
Seagen, a wholly owned subsidiary of Pfizer31
ACADIA Pharmaceuticals Inc.21
Acrotech Biopharma Inc.11
AriBio Co., Ltd.10
Azienda Ospedaliera Cardinale G. Panico10
Biogen10
Bristol-Myers Squibb11
Denali Therapeutics Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.